INAB
IN8bio, Inc. Common StockstockNASDAQ
At CloseNov 16, 2026 3:59:37 PM EST
0.82USD-0.012%(-0.00)5,090,196
Pre-marketNov 17, 2026 9:16:30 AM EST
0.7699USD-5.650%(-0.0461)
After-hoursNov 16, 2026 4:59:30 PM EST
0.7718USD-5.867%(-0.0481)
Loading…
Loading…
9.02M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$0.82
Beta
1.38
52-Week High
$2.73 2026-01-16
52-Week Low
$0.72 2026-11-16
SMA 50
$1.10
SMA 200
$1.38
Avg. Vol 10D
540,086
Avg. Vol 30D
203,338
Avg. Vol 90D
107,070
Relative Vol
25.03
10.81M
8.13M
75.24%
15,733
0.22%
1.00
33%/67%
18.84%
13.37%
3.1100%
25,000
607
607
Jun 6, 2025 · 1-for-30 (reverse)
-19.4M
-1.19
-141.83
Nov 16, 2026
IN8bio reports survival data from glioblastoma trial ·
Investing.com
Nov 6, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ·
GlobeNewswire Inc.
INAB Profile
in8bio, inc. ("in8bio") is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta t cells. we are developing a broad portfolio of programs and are the first company to advance genetically modified gamma-delta t cells into the clinic.
INAB Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.90 | 2026-11-10 | -7.28% | -0.813 |
| 1M | 1.11 | 2026-10-16 | -24.82% | 1.680 |
| 3M | 1.11 | 2026-08-17 | -24.82% | 1.417 |
| 6M | 1.42 | 2026-05-18 | -41.23% | 1.171 |
| 1Y | 1.59 | 2025-11-17 | -47.52% | 1.382 |
| 2Y | 9.95 | 2024-11-18 | -91.61% | — |
| 5Y | 241.50 | 2021-11-17 | -99.65% | 0.494 |
INAB Stock Summary
IN8bio, Inc. Common Stock (NASDAQ:INAB) stock price today is $0.83, and today's volume is 5,090,196. INAB is up 1.768% today. The 30 day average volume is 203,338. INAB market cap is $9.02M with 10.81M shares outstanding.